STM publisher Elsevier, Netherlands, and the American College of Cardiology (ACC) have announced that the American College of Cardiology (ACC) journals' portfolio has been expanded with the launch of JACC: Heart Failure. It is expected that this new journal will better meet the demands and challenges of treating what is now the most rapidly increasing category of cardiac disease. The first publication is now available online at heartfailure.onlinejacc.org.
Dr. Christopher O'Connor will serve as Editor-in-Chief of the journal. Each bi-monthly issue will present high-quality content, authored by experts worldwide, with a unique focus on new research and treatment options. It is projected to take its place among the top journals in the world for the understanding of the pathophysiology, diagnosis, treatment, and care of heart failure patients with the intent to improve our understanding of the disease, clinical trials, clinical outcomes, and advances in therapies through scientific communication.
A state-of-the-condition update by Dr. Eugene Braunwald and the breadth of articles featured in the first issue are an example of the journal's aims to publish the full range of topics related to this condition – including basic and translational science, trials and registries, co-morbidities, biomarkers, advanced heart failure, and outcomes.
